comparing glp-1 agonists Receptor Agonists: An Alternative for Rapid-Acting Insulin? The New Weight Management Meds
Description
Bach-Kliegel, F
Ozempic is designed for managing type 2 diabetes, while Wegovy is specifically approved for weight loss
Another possibility is that GIP reduces the metabolic adaptation that typically occurs during weight loss, where energy expenditure decreases more than predicted by changes in body mass
When engaged, the receptor initiates cascades that influence metabolism, inflammation, cell survival, and neural activity
We are looking at not just your, uh, weight, but your body composition as well
[DOI] [PMC free article] [PubMed] [Google Scholar] 37.Obesity Medications: What Does the Future Hold
